VRAX

Virax Biolabs Group LimitedNASDAQHealthcare

$0.15-12.18%ClosedMarket Cap: $663,451

As of 2026-04-07

Analyst Consensus

Consensus

Buy

Target (Consensus)

$1.00

Target (Median)

$1.00

Target Range

$1.00 - $1.00

Upside from current price: 554.5%

Rating Distribution

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-01-09	HC Wainwright & Co.	maintain	Buy	Buy

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Sun Mar 31	$-1.90	$1.4M	1
Mon Mar 31	$-1.48	$25.0K	1
Tue Mar 31	$-0.40	$40.0K	1
Wed Mar 31	$-0.24	$4.0K	1